QUALITY ASSURANCE, BUSINESS PLANNING & ANALYSIS, AND PROJECT MANAGEMENT
- 18 years in pharmaceutical quality systems, technical writing, metrics, and project management.
ICH/GCP and GMP, Quality Systems (Document Management/Training), Project Coordination and Management, Costs and Operational Efficiencies, Organizational Data Analysis, Strategic Mapping, Training, eTMF Inspection Preparedness, Budgeting and Headcount Analysis, Metrics and Goals Reporting, Continuous Improvement, SOP Development, Process Mapping, Internal Auditing for Training, and Technical Writing. Special expertise: SharePoint, Veeva, and Trackwise.
2017 – Present Tesaro, Waltham, MA
2017 – 2017 Aegerion, Cambridge, MA
2016 – 2017 Seres, Cambridge, MA
2016 – 2016 Keryx, Boston, MA
2013 – 2016 Agios, Cambridge, MA
2013 – 2013 Alnylam, Cambridge, MA
2011 – 2012 Biogen, Cambridge, MA
2011 – Present MG Quality Microbiology, LLC
1999 – 2011 Pfizer (Wyeth Biotech), Quality Business Planning Manager
Business Planning Activities
Managed Quality Agreement program for the Andover Site (including co-testing/co-manufacturing agreements). Managed annual operating ($52MM) and capital ($120MM) budgets. Coordinated salary planning activities. Assisted in the development of KPIs and reporting. Supported the development of goals and objectives for site and quality. Participated in weekly site leadership meetings and Lean Six Sigma training/activities. Collaborated with Facilities regarding space planning.
Project Management Activities
Led global team in a project to deliver headcount and organizational data analysis. Identified and implemented a continuous improvement project to streamline and utilize electronic workflows. Headed global team to gain alignment on quality agreement program and strategy. Collaborated on development of project portfolio management program. Created five-year strategic map. Developed and maintained SharePoint site(s) for quality unit and trained administrative staff on maintenance. Developed and managed quality archive. Created TMF indices/files for four clinical studies. Assisted in post- close-out management of eTMF for three studies. Supported implementation of EDMS.